These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8415237)

  • 1. Therapeutic drug monitoring. Principles and practice.
    Preskorn SH; Burke MJ; Fast GA
    Psychiatr Clin North Am; 1993 Sep; 16(3):611-45. PubMed ID: 8415237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.
    Preskorn SH
    J Psychiatr Pract; 2010 May; 16(3):177-82. PubMed ID: 20485106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
    Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic drug monitoring (TDM) of psychotropic drugs: a consensus guideline of the AGNP-TDM group].
    Baumann P; Hiemke C; Ulrich S; Eckermann G; Kuss HL; Laux G; Müller-Oerlingenhausen B; Rao ML; Riederer P; Zernig G; ;
    Rev Med Suisse; 2006 May; 2(67):1413-8, 1420-2, 1424-6. PubMed ID: 16786958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and therapeutic drug monitoring of psychotropic drugs in pediatrics.
    Pichini S; Papaseit E; Joya X; Vall O; Farré M; Garcia-Algar O; de laTorre R
    Ther Drug Monit; 2009 Jun; 31(3):283-318. PubMed ID: 19363463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug monitoring and regulatory aspects of psychotropic drugs in childhood and adolescence].
    Hebebrand J; Gerlach M
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):280-2. PubMed ID: 20306786
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic drug monitoring of psychoactive drugs during pregnancy in the genomic era: challenges and opportunities.
    DeVane CL; Stowe ZN; Donovan JL; Newport DJ; Pennell PB; Ritchie JC; Owens MJ; Wang JS
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):54-9. PubMed ID: 16785271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].
    Stephan PL; Etzensberger M; Jaquenoud Sirot E
    Praxis (Bern 1994); 2006 Apr; 95(17):671-8. PubMed ID: 16686323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations].
    Gerlach M; Rothenhöfer S; Mehler-Wex C; Fegert JM; Schulz E; Wewetzer C; Warnke A
    Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):5-13. PubMed ID: 16485609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
    Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
    Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions in psychopharmacology.
    Callahan AM; Fava M; Rosenbaum JF
    Psychiatr Clin North Am; 1993 Sep; 16(3):647-71. PubMed ID: 8415238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic drug monitoring in epileptology and psychiatry].
    Brandt C; Baumann P; Eckermann G; Hiemke C; May TW; Rambeck B; Pohlmann-Eden B
    Nervenarzt; 2008 Feb; 79(2):167-74. PubMed ID: 17701390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.
    Eilers R
    Clin Pharmacokinet; 1995 Dec; 29(6):442-50. PubMed ID: 8787949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Therapeutic drug monitoring", a strategy for improving drug safety in child and adolescent psychiatry and psychotherapy].
    Gerlach M; Schulz E; Fegert JM
    Z Kinder Jugendpsychiatr Psychother; 2005 Jul; 33(3):157-8. PubMed ID: 16097263
    [No Abstract]   [Full Text] [Related]  

  • 15. Key concepts in geriatric psychopharmacology. Altered pharmacokinetics and polypharmacy.
    Salzman C
    Psychiatr Clin North Am; 1982 Apr; 5(1):181-90. PubMed ID: 7099992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic pharmacokinetic principles and their application to psychotropic drugs.
    Greenblatt DJ
    J Clin Psychiatry; 1993 Sep; 54 Suppl():8-13; discussion 55-6. PubMed ID: 8407859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring in Italian psychiatry.
    Conca A; Schmidt E; Pastore M; Hiemke C; Duffy D; Giupponi G
    Pharmacopsychiatry; 2011 Sep; 44(6):259-62. PubMed ID: 21959788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.
    Rougemont M; Ulrich S; Hiemke C; Corruble E; Baumann P
    Fundam Clin Pharmacol; 2010 Jun; 24(3):377-84. PubMed ID: 20199581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy: when is it rational?
    Preskorn SH; Lacey RL
    J Psychiatr Pract; 2007 Mar; 13(2):97-105. PubMed ID: 17414685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs.
    Hendset M; Haslemo T; Rudberg I; Refsum H; Molden E
    Pharmacopsychiatry; 2006 Jul; 39(4):121-7. PubMed ID: 16871467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.